The role of FGF21 in HFpEF is not fully understood. Here, the authors show that circulating levels of FGF21 are elevated in patients with HFpEF and that it protects against HFpEF by triggering multiorgan crosstalk among the liver, adipose tissue, and the heart, suggesting that FGF21 could be a promising therapeutic target for treating HFpEF.
- Ke Zhang
- Jing Gan
- Zhuofeng Lin